Free Daily Headlines :

  • COVID-19
  • Vaccine Info
  • Money
  • Politics
  • Education
  • Health
  • Justice
  • More
    • Environment
    • Economic Development
    • Gaming
    • Investigations
    • Social Services
    • TRANSPORTATION
  • Opinion
    • CT Viewpoints
    • CT Artpoints
DONATE
Reflecting Connecticut’s Reality.
    COVID-19
    Vaccine Info
    Money
    Politics
    Education
    Health
    Justice
    More
    Environment
    Economic Development
    Gaming
    Investigations
    Social Services
    TRANSPORTATION
    Opinion
    CT Viewpoints
    CT Artpoints

LET�S GET SOCIAL

Show your love for great stories and out standing journalism

New stem cell research covers bad knees to schizophrenia

  • by Arielle Levin Becker
  • July 21, 2011
  • View as "Clean Read" "Exit Clean Read"

Antibiotics, antivirals and other drugs have helped countless people, but for some, they can also cause liver damage. There’s no way to tell who’s susceptible until after it happens, and until recently, scientists trying to develop ways to find out sooner faced significant obstacles.

For one thing, taking liver cells from a person for research isn’t ethically permissible. And the livers of mice and rats aren’t exactly the same as those in humans.

Now three professors at the University of Connecticut School of Pharmacy are working to get around those problems using stem cells that can be turned into liver cells. Researchers Urs A. Boelsterli, Theodore Rasmussen, and Winfried Krueger hope to figure out why drugs cause liver damage in some people, which could potentially lead to a way to tell who is, and isn’t, at risk from certain certain drugs.

Ted Rasmussen

Theodore Rasmussen: the stem cell specialist (Jordan Bender/UConn Photo)

Their work is one of 20 stem cell research projects awarded state funding this week. Overall, the Stem Cell Research Advisory Committee awarded $9.8 million in grants, the latest round of funding in the state’s 10-year, $100 million commitment to the work. This week’s grant awards mark the fifth round of funding; since 2006, the committee has awarded more than $60 million. The money comes from the state’s tobacco settlement fund.

This year’s grant recipients also include nine projects by researchers at the UConn Health Center, nine at Yale University and one at Wesleyan University. The grants will fund work on topics including heart defects related to Down syndrome, treatment of cartilage damage and a risk factor for schizophrenia.

One grant, for $1.29 million, went to Chondrogenics, Inc., a start-up company that grew out of the work of Caroline Dealy, a professor at the UConn Health Center who is studying ways to create cartilage using stem cells. The goal is to develop cartilage that could be used replace damaged cartilage in patients with osteoarthritis.

“These awards signal Connecticut’s commitment to stem cell research and the life sciences sector,” Gov. Dannel P. Malloy said in a statement released by his office. “Connecticut continues to conduct some of the finest stem cell research in the country, and these awardees further demonstrate Connecticut’s promise as a leader in bioscience.”

For their work, Rasmussen, Boelsterli and Krueger were awarded a three-year grant for $1.29 million.

Most people are able to tolerate medications without liver damage, but Boelsterli said that many of the drugs that can cause liver problems are so widely used that even a small percentage of patients with adverse effects amounts to a lot of people.

The question he wants to answer: “Why are certain individuals predisposed to developing this toxicity and the vast majority is not susceptible?”

Figuring out what causes some people to get liver damage could lead to the development of predictive tests to identify people at risk before they are prescribed medication.

Boelsterli had been studying drug-induced liver toxicity for years when he and his colleagues learned about techniques involving stem cells. In them, he said, they saw great potential.

Stem cells are considered particularly promising because they have the potential to turn into any type of cell. Scientists can use them to study what causes cells to develop in certain ways, how diseases develop, and to create new cells like neurons or human liver cells that would otherwise be difficult to get in large quantities–or at all–for research.

Winfried Krueger

Winfried Krueger: the genetics expert (UConn)

“You can’t go to a patient, you can’t say ‘we’d like to have a brain biopsy, please, so we can study what’s going on,'” Rasmussen said. “In general, you can’t get these invasive biopsies from patients just to study disease mechanisms.”

While human embryonic stem cells have provoked controversy, the stem cells Rasmussen, Boelsterli and Krueger will use are known as induced pluripotent stem cells, or iPS cells, which don’t involve embryos.

Instead, they are created from cells that have already differentiated. By introducing certain genes to them, scientists can turn them into stem cells that are not differentiated and have the potential to become any type of cell. Then researchers can coax them to become a certain type of cell. Rasmussen’s lab will start with skin cells from patients who have had drug-induced liver injuries, and from those who haven’t, and end up with liver cells.

One advantage of iPS cells is that they retain the genetic characteristics of the person they came from, so iPS cells derived from the skin cells of a person with a genetic disease that get turned into liver cells would be expected to exhibit the characteristics of the liver of a person with that disease.

Then, Boelsterli said, researchers will look at how the cells function, comparing those from patients with drug-induced liver injuries to those from patients without them.

They will also expose the cells to drugs known to cause adverse effects to see how the cells react, comparing those from patients with liver damage to those who did not get it.

Krueger, meanwhile, is interested in whether there is a genetic basis for drug-induced liver injury. Exploring that will involve exposing the cells to particular drugs and determining whether certain genes are expressed more or less than they otherwise would be. Krueger said the literature is divided on whether there is a genetic link to the drug reactions.

“Obviously, something has to change in response to the drug,” he said, and the researchers hope to determine what it is.

Boelsterli and Rasmussen stressed that the project represents a collaboration between researchers with different interests and expertise. Rasmussen specializes in stem cells, while Boelsterli has an expertise in liver toxicity and Krueger is an expert in genetics.

“None of us could do it by ourselves,” Boelsterli said.

Rasmussen said that in addition to potential advances in science and the benefits to people’s lives they can create, research at universities in the state can foster biotechnology companies and the jobs they create.

“It’s got to happen somewehere, so why not here?” he said.

Sign up for CT Mirror's free daily news summary.

Free to Read. Not Free to Produce.

The Connecticut Mirror is a nonprofit newsroom. 90% of our revenue comes from people like you. If you value our reporting please consider making a donation. You'll enjoy reading CT Mirror even more knowing you helped make it happen.

YES, I'LL DONATE TODAY

ABOUT THE AUTHOR

Arielle Levin Becker

SEE WHAT READERS SAID

RELATED STORIES
New Haven’s school challenge: How to spend all that federal money
by Thomas Breen | New Haven Independent

How does it spend $136 million in federal pandemic relief without getting hooked on the short-term dough?

Biden moves to overturn Trump birth control rules
by Julie Rovner | Kaiser Health News

The Biden administration has formally proposed the repeal of Trump-era regulations barring abortion referrals.

New Britain residents weren’t getting vaccinated. So city officials got creative.
by Dave Altimari

The city's efforts are a microcosm of what is happening across the country as officials struggle to vaccinate vulnerable residents.

CT’s vaccine advisory group is on hold as members ask what’s next
by Jenna Carlesso

Dozens of experts are on the sidelines. Some say their work is done; others say they could have done more.

College students in Connecticut should be vaccinated now
by Dayna Vadala

If the state of Connecticut wants its institutions of higher learning to return to normal in the fall, it’s going to have to get shots into the arms of the students.

Support Our Work

Show your love for great stories and outstanding journalism.

$
Select One
  • Monthly
  • Yearly
  • Once
Artpoint painter
CT ViewpointsCT Artpoints
Opinion College students in Connecticut should be vaccinated now
by Dayna Vadala

If the state of Connecticut wants its institutions of higher learning to return to normal in the fall, it’s going to have to get shots into the arms of the students.

Opinion Connecticut, be a International leader against hair discrimination among children
by Faith D. Crittenden, Jade A. Anderson, MD, and Whitney L. Stuard

On March 1, 2020, Connecticut became the eighth state to pass the Crown Act, a national legislative movement that recognizes natural hair and cultural headwear discrimination as a form of racial discrimination in the workplace. While we are  in strong support and advocate for this law, it is important to recognize the limitations of the Crown Act and how it can be improved upon in future policy.

Opinion Three lessons for schools across America from Secretary Cardona’s hometown
by Mark Benigni

Over the past decade, Meriden Public Schools -- where U.S. Education Secretary Miguel Cardona served as assistant superintendent -- has become a unique laboratory for new ideas that push the boundaries of what is possible in public education. And many of those ideas have paid off.

Opinion A healthcare system too broken to fix
by Sosena Kedebe MD

On March 25, the White house announced that it was going to invest over $6 billion in health centers that are funded through the Resources and Services Administration (HRSA) in order to expand COVID-19 vaccinations and other health services provided to vulnerable populations. As a chief medical officer for a health center that is strained to reach some of the most disenfranchised patient population in Hartford, this was great news. Yet there was a part of me that took the news with a deep concern. Why you might ask?

Artwork Grand guidance
by Anne:Gogh

In a world of systemic oppression aimed towards those of darker skintones – representation matters. We are more than our equity elusive environments, more than numbers in a prison and much more than victims of societal dispositions. This piece depicts a melanated young man draped in a cape ascending high above multiple forms of oppression. […]

Artwork Shea
by Anthony Valentine

Shea is a story about race and social inequalities that plague America. It is a narrative that prompts the question, “Do you know what it’s like to wake up in new skin?”

Artwork The Declaration of Human Rights
by Andres Chaparro

Through my artwork I strive to create an example of ideas that reflect my desire to raise social consciousness, and cultural awareness. Jazz music is the catalyst to all my work, and plays a major influence in each piece of work.”

Artwork ‘A thing of beauty. Destroy it forever’
by Richard DiCarlo | Derby

During times like these it’s often fun to revisit something familiar and approach things with a different slant. I have been taking some Pop culture and Art masterpieces and applying the vintage 1960’s and 70’s classic figures (Fisher Price, little people) to the make an amusing pieces. Here is my homage to Fisher -Price, Yellow […]

Twitter Feed
A Twitter List by CTMirror

Engage

  • Reflections Tickets & Sponsorships
  • Events
  • Donate
  • Newsletter Sign-Up
  • Submit to Viewpoints
  • Submit to ArtPoints
  • Economic Indicator Dashboard
  • Speaking Engagements
  • Commenting Guidelines
  • Legal Notices
  • Contact Us

About

  • About CT Mirror
  • Announcements
  • Board
  • Staff
  • Sponsors and Funders
  • Donors
  • Friends of CT Mirror
  • History
  • Financial
  • Policies
  • Strategic Plan

Opportunity

  • Advertising and Sponsorship
  • Speaking Engagements
  • Use of Photography
  • Work for Us

Go Deeper

  • Steady Habits Podcast
  • Economic Indicator Dashboard
  • Five Things

The Connecticut News Project, Inc. 1049 Asylum Avenue, Hartford, CT 06105. Phone: 860-218-6380

© Copyright 2021, The Connecticut News Project. All Rights Reserved. Website by Web Publisher PRO